{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:51:25Z","timestamp":1793195485264,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Xuzhou Education Science 14th Five-Year Plan","award":["GH14-23-L177"],"award-info":[{"award-number":["GH14-23-L177"]}]},{"name":"Jiangsu Provincial Health Vocational Education Research Project","award":["WJ202407"],"award-info":[{"award-number":["WJ202407"]}]},{"name":"the Jiangsu Qinglan Project (2022), Basic Research for Application Projects","award":["KC21264"],"award-info":[{"award-number":["KC21264"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.prp.2025.156046","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T11:55:48Z","timestamp":1748260548000},"page":"156046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["The paradoxical role of IFN-\u03b3 in cancer: Balancing immune activation and immune evasion"],"prefix":"10.1016","volume":"272","author":[{"given":"Xiaojuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.156046_bib1","article-title":"Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: IFN-\u03b3-dependent or independent pathway","volume":"155","author":"Ding","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib2","first-page":"2093","article-title":"Challenges of Using IFN\u03b3 in Clinical Settings","volume":"83","author":"Singh","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib3","first-page":"991","article-title":"The role of IFN-\u03b3-signalling in response to immune checkpoint blockade therapy","volume":"67","author":"Wong","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib4","first-page":"1","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib5","article-title":"Pan-cancer analysis of IFN-\u03b3 with possible immunotherapeutic significance: a verification of single-cell sequencing and bulk omics research","volume":"14","author":"Wei","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib6","first-page":"89","article-title":"Dual role of interferon-gamma in the response of melanoma patients to immunotherapy with immune checkpoint inhibitors","volume":"24","author":"Wawrzyniak","year":"2025"},{"key":"10.1016\/j.prp.2025.156046_bib7","article-title":"A myeloid IFN gamma response gene signature correlates with cancer prognosis","volume":"15","author":"Zhang","year":"2025"},{"key":"10.1016\/j.prp.2025.156046_bib8","first-page":"351","article-title":"Interferon-gamma signaling promotes melanoma progression and metastasis","volume":"42","author":"Zhou","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib9","unstructured":"A. Ahn, Constitutive PD-L1 expression in melanoma, 2019."},{"key":"10.1016\/j.prp.2025.156046_bib10","first-page":"413","article-title":"The aryl hydrocarbon receptor controls IFN-\u03b3-induced immune checkpoints PD-L1 and IDO via the JAK\/STAT pathway in lung adenocarcinoma","volume":"214","author":"Snyder","year":"2025"},{"key":"10.1016\/j.prp.2025.156046_bib11","first-page":"1865","article-title":"Radiotherapy enhances CXCR3highCD8+\u2009T cell activation through inducing IFN\u03b3-mediated CXCL10 and ICAM-1 expression in lung cancer cells","volume":"72","author":"Wang","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib12","first-page":"46","article-title":"Effects of IFN-\u03b3 on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms","volume":"24","author":"Zhao","year":"2024"},{"key":"10.1016\/j.prp.2025.156046_bib13","first-page":"1513421","article-title":"Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review","volume":"15","author":"Serrano Garc\u00eda","year":"2024"},{"key":"10.1016\/j.prp.2025.156046_bib14","first-page":"6053","article-title":"Interferon-\u03b3 in the tumor microenvironment promotes the expression of B7H4 in colorectal cancer cells, thereby inhibiting cytotoxic T cells","volume":"14","author":"Jing","year":"2024"},{"key":"10.1016\/j.prp.2025.156046_bib15","first-page":"1","article-title":"Fates of CD8+\u2009T cells in tumor microenvironment","volume":"17","author":"Maimela","year":"2019"},{"key":"10.1016\/j.prp.2025.156046_bib16","first-page":"89","article-title":"The dark side of IFN-\u03b3: its role in promoting cancer immunoevasion","volume":"19","author":"Mojic","year":"2017"},{"key":"10.1016\/j.prp.2025.156046_bib17","first-page":"869","article-title":"Association of CD8+\u2009TILs co-expressing granzyme A and interferon-\u03b3 with colon cancer cells in the tumor microenvironment","volume":"24","author":"Yang","year":"2024"},{"key":"10.1016\/j.prp.2025.156046_bib18","first-page":"991","article-title":"The role of IFN-\u03b3-signalling in response to immune checkpoint blockade therapy","volume":"67","author":"Wong","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib19","first-page":"1034","article-title":"Chloroquine reverses chemoresistance via upregulation of p21WAF1\/CIP1 and autophagy inhibition in ovarian cancer","volume":"11","author":"Hwang","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib20","article-title":"Methionine enkephalin (MENK) suppresses lung cancer by regulating the Bcl-2\/Bax\/caspase-3 signaling pathway and enhancing natural killer cell-driven tumor immunity","volume":"98","author":"Zhang","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib21","first-page":"19712","article-title":"The up-regulation of human caspase-8 by interferon-\u03b3 in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1","volume":"279","author":"Ruiz-Ruiz","year":"2004"},{"key":"10.1016\/j.prp.2025.156046_bib22","first-page":"1962591","article-title":"IFN-\u03b3-induced ER stress impairs autophagy and triggers apoptosis in lung cancer cells","volume":"10","author":"Fang","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib23","first-page":"864","article-title":"TNF-\u03b1 synergises with IFN-\u03b3 to induce caspase-8-JAK1\/2-STAT1-dependent death of intestinal epithelial cells","volume":"12","author":"Woznicki","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib24","first-page":"423","article-title":"Interferon-\u03b3 primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway","volume":"55","author":"Simpson","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib25","article-title":"Down-regulation of A20 promotes immune escape of lung adenocarcinomas","volume":"13","author":"Breitenecker","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib26","first-page":"5530","article-title":"The multifaceted role of TRAIL signaling in cancer and immunity","volume":"288","author":"Cardoso Alves","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib27","first-page":"5641","article-title":"Mesenchymal stem cells combined with IFN\u03b3 induce apoptosis of breast cancer cells partially through TRAIL","volume":"40","author":"Yenilmez","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib28","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154133","article-title":"Engagement of TRAIL triggers degranulation and IFN\u03b3 production in human natural killer cells","volume":"23","author":"H\u00f6fle","year":"2022","journal-title":"EMBO Rep."},{"key":"10.1016\/j.prp.2025.156046_bib29","first-page":"2934","article-title":"NF-\u03baB protects cells from gamma interferon-induced RIP1-dependent necroptosis","volume":"31","author":"Thapa","year":"2011"},{"key":"10.1016\/j.prp.2025.156046_bib30","first-page":"134","article-title":"Inhibition of keratinocyte necroptosis mediated by RIPK1\/RIPK3\/MLKL provides a protective effect against psoriatic inflammation","volume":"11","author":"Duan","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib31","first-page":"522","article-title":"Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinoma","volume":"37","author":"McCormick","year":"2016"},{"key":"10.1016\/j.prp.2025.156046_bib32","first-page":"94","article-title":"RIPK1 suppresses a TRAF2-dependent pathway to liver cancer","volume":"31","author":"Schneider","year":"2017"},{"key":"10.1016\/j.prp.2025.156046_bib33","first-page":"161","article-title":"RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases","volume":"27","author":"Patel","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib34","first-page":"653","article-title":"Regulated cell death in cancer: from pathogenesis to treatment","volume":"136","author":"Gong","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib35","first-page":"1585","article-title":"RNF31 promotes tumorigenesis via inhibiting RIPK1 kinase-dependent apoptosis","volume":"42","author":"Zhang","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib36","first-page":"671","article-title":"The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade","volume":"55","author":"Cucolo","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib37","first-page":"201","article-title":"Regulation of tumor growth by IFN-\u03b3 in cancer immunotherapy","volume":"24","author":"Beatty","year":"2001"},{"key":"10.1016\/j.prp.2025.156046_bib38","first-page":"2131","article-title":"IFN-\u03b3 critically enables the intratumoural infiltration of CXCR3+\u2009CD8+\u2009T cells to drive squamous cell carcinoma regression","volume":"13","author":"Zeng","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib39","first-page":"95","article-title":"The roles of IFN\u03b3 in protection against tumor development and cancer immunoediting","volume":"13","author":"Ikeda","year":"2002"},{"key":"10.1016\/j.prp.2025.156046_bib40","first-page":"1355","article-title":"TNF-\u03b1 increases IP-10 expression in MCF-7 breast cancer cells via activation of the JNK\/c-Jun pathways","volume":"11","author":"Kochumon","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib41","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.141326","article-title":"STAT4 is expressed in neutrophils and promotes antimicrobial immunity","volume":"6","author":"Mehrpouya-Bahrami","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.prp.2025.156046_bib42","first-page":"57","article-title":"IFN-\u03b3 inhibits ovarian cancer progression via SOCS1\/JAK\/STAT signaling pathway","volume":"24","author":"Gao","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib43","first-page":"158","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib44","article-title":"Evolution of the interferon response: lessons from ISGs of diverse mammals","volume":"53","author":"McDougal","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib45","first-page":"95","article-title":"Interferon regulatory factor 1 (IRF-1) activates anti-tumor immunity via CXCL10\/CXCR3 axis in hepatocellular carcinoma (HCC)","volume":"506","author":"Yan","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib46","first-page":"101","article-title":"Interferon regulatory factor 1 (IRF-1) downregulates Checkpoint kinase 1 (CHK1) through miR-195 to upregulate apoptosis and PD-L1 expression in Hepatocellular carcinoma (HCC) cells","volume":"125","author":"Yan","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib47","first-page":"1891","article-title":"Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells","volume":"69","author":"Yan","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib48","article-title":"Targeting SHP2 as a promising strategy for cancer immunotherapy","volume":"152","author":"Liu","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib49","article-title":"Epithelial-to-mesenchymal transition hinders interferon-\u03b3-dependent immunosurveillance in lung cancer cells","volume":"539","author":"Tseng","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib50","first-page":"525","article-title":"IL-17 promotes hepatocellular carcinoma through inhibiting apoptosis induced by IFN-\u03b3","volume":"522","author":"Li","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib51","first-page":"3737","article-title":"Low-dose IFN\u03b3 induces tumor cell stemness in tumor microenvironment of non\u2013small cell lung cancer","volume":"79","author":"Song","year":"2019"},{"key":"10.1016\/j.prp.2025.156046_bib52","series-title":"Drug Des Devel Ther","first-page":"1527","article-title":"Interferon-\u03b3 and celecoxib inhibit lung-tumor growth through modulating M2\/M1 macrophage ratio in the tumor microenvironment","author":"Ren","year":"2014"},{"key":"10.1016\/j.prp.2025.156046_bib53","first-page":"20","article-title":"IFN-\u03b3 surmounts PD-L1\/PD1 inhibition to CAR-T cell therapy by upregulating ICAM-1 on tumor cells","volume":"6","author":"Dong","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib54","first-page":"364","article-title":"Overall review of curative impact and barriers of CAR-T cells in osteosarcoma","volume":"23","author":"Li","year":"2024","journal-title":"EXCLI J."},{"key":"10.1016\/j.prp.2025.156046_bib55","first-page":"1960728","article-title":"Antitumor activity of the third generation EphA2 CAR-T cells against glioblastoma is associated with interferon gamma induced PD-L1","volume":"10","author":"An","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib56","first-page":"1425","article-title":"CAR T-cell entry into tumor islets is a two-step process dependent on IFN\u03b3 and ICAM-1","volume":"9","author":"Kantari-Mimoun","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib57","first-page":"931","article-title":"IFN-\u03b3-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling","volume":"143","author":"Gao","year":"2018"},{"key":"10.1016\/j.prp.2025.156046_bib58","first-page":"2008110","article-title":"T cell-mediated elimination of cancer cells by blocking CEACAM6\u2013CEACAM1 interaction","volume":"11","author":"Pinkert","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib59","first-page":"143","article-title":"Screening and clinical significance of tumor markers in head and neck squamous cell carcinoma through bioinformatics analysis","volume":"19","author":"Zhao","year":"2019"},{"key":"10.1016\/j.prp.2025.156046_bib60","series-title":"Clinical and Translational Oncology","first-page":"1","article-title":"IFN-\u03b3 affects pancreatic cancer properties by MACC1-AS1\/MACC1 axis via AKT\/mTOR signaling pathway","author":"Shi","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib61","first-page":"980","article-title":"Pro-inflammatory TNF-\u03b1 and IFN-\u03b3 promote tumor growth and metastasis via induction of MACC1","volume":"11","author":"Kobelt","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib62","article-title":"mTOR-mediated regulation of immune responses in cancer and tumor microenvironment","volume":"12","author":"Mafi","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib63","first-page":"934","article-title":"The prognostic significance of MACC1 expression in breast cancer and its relationship to immune cells in the tumor microenvironment and patient survival","volume":"57","author":"Ali","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib64","first-page":"7044","article-title":"MACC1 regulates PDL1 expression and tumor immunity through the c-Met\/AKT\/mTOR pathway in gastric cancer cells","volume":"8","author":"Tong","year":"2019"},{"key":"10.1016\/j.prp.2025.156046_bib65","article-title":"Curcumin enhances anti-tumor immunity in anaplastic thyroid carcinoma by elevating CD8+\u2009T cell function and downregulating the AKT\/mTORC1\/STAT3\/PD-L1 axis","volume":"269","author":"Zheng","year":"2025"},{"key":"10.1016\/j.prp.2025.156046_bib66","article-title":"Anti-angiogenic agents in combination with immune checkpoint inhibitors: a promising strategy for cancer treatment","volume":"11","author":"Song","year":"1956"},{"key":"10.1016\/j.prp.2025.156046_bib67","first-page":"2276","article-title":"IFN-\u03b3-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+\u2009T cells requires tumor responsiveness to IFN-\u03b3","volume":"166","author":"Beatty","year":"2001"},{"key":"10.1016\/j.prp.2025.156046_bib68","first-page":"292","article-title":"Inhibition of FGFR reactivates IFN\u03b3 signaling in tumor cells to enhance the combined antitumor activity of lenvatinib with anti-PD-1 antibodies","volume":"82","author":"Adachi","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib69","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3727\/096504014X13890370410285","article-title":"Inhibition of tumor angiogenesis by interferon-\u03b3 by suppression of tumor-associated macrophage differentiation","volume":"21","author":"Sun","year":"2014","journal-title":"Oncol. Res."},{"key":"10.1016\/j.prp.2025.156046_bib70","first-page":"240","article-title":"Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer","volume":"2","author":"Haabeth","year":"2011"},{"key":"10.1016\/j.prp.2025.156046_bib71","series-title":"Tumor Microenvironment: The Role of Chemokines\u2013Part A","first-page":"45","article-title":"The multifaceted roles of CXCL9 within the tumor microenvironment","author":"Neo","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib72","first-page":"4668","article-title":"ERK1\/2 signaling induces upregulation of ANGPT2 and CXCR4 to mediate liver metastasis in colon cancer","volume":"80","author":"Urosevic","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib73","first-page":"1247","article-title":"A CXCR4 inhibitor (balixafortide) enhances docetaxel-mediated antitumor activity in a murine model of prostate cancer bone metastasis","volume":"83","author":"Robinson","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib74","article-title":"Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response","volume":"131","author":"von Locquenghien","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib75","article-title":"Evaluation of the presence of Th1 response through T-bet and IFN-gamma immunohistochemical expression in lower lip and oral tongue squamous cell carcinomas","volume":"253","author":"Rodrigues","year":"2024"},{"key":"10.1016\/j.prp.2025.156046_bib76","article-title":"The potential role of follicular helper T cells and helper T cells type 1 in Warthin tumour","volume":"220","author":"Kobayashi","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib77","first-page":"1234","article-title":"An IFN\u03b3\/STAT1\/JMJD3 axis induces ZEB1 expression and promotes aggressiveness in lung adenocarcinoma","volume":"19","author":"Yang","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib78","article-title":"The role of cytokines in the evolution of cancer: IFN-\u03b3 paradigm","volume":"151","author":"Todorovi\u0107-Rakovi\u0107","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib79","first-page":"a028480","article-title":"Interferon \u03b3 and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity","volume":"11","author":"Alspach","year":"2019"},{"key":"10.1016\/j.prp.2025.156046_bib80","article-title":"Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles","volume":"4","author":"Ricklefs","year":"2018"},{"key":"10.1016\/j.prp.2025.156046_bib81","first-page":"3044","article-title":"Nasopharyngeal cancer cell-derived exosomal PD-L1 inhibits CD8+\u2009T-cell activity and promotes immune escape","volume":"113","author":"Yang","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib82","first-page":"1","article-title":"IRAK1-regulated IFN-\u03b3 signaling induces MDSC to facilitate immune evasion in FGFR1-driven hematological malignancies","volume":"20","author":"Cai","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib83","first-page":"602","article-title":"Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-\u03b3-signaling mutant cancer cells","volume":"11","author":"Williams","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib84","first-page":"1","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib85","first-page":"382","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018"},{"key":"10.1016\/j.prp.2025.156046_bib86","first-page":"S239","article-title":"Emapalumab for the Treatment of Toxicities Associated with CD19 CAR-T Cells in Adult Patients","volume":"31","author":"Johnson","year":"2025"},{"key":"10.1016\/j.prp.2025.156046_bib87","first-page":"2930","article-title":"IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017"},{"key":"10.1016\/j.prp.2025.156046_bib88","first-page":"270","article-title":"CD8+\u2009T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019"},{"key":"10.1016\/j.prp.2025.156046_bib89","first-page":"1148","article-title":"Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-\u03b3 and IL-12","volume":"49","author":"Garris","year":"2018"},{"key":"10.1016\/j.prp.2025.156046_bib90","first-page":"1875","article-title":"Role of MAPK activity in PD-L1 expression in hepatocellular carcinoma cells","volume":"25","author":"Xing","year":"2020","journal-title":"J. BUON"},{"key":"10.1016\/j.prp.2025.156046_bib91","first-page":"2966","article-title":"High PD-L1\/CD274 expression of monocytes and blood dendritic cells is a risk factor in lung cancer patients undergoing treatment with PD1 inhibitor therapy","volume":"12","author":"Riemann","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib92","first-page":"1208","article-title":"Interferon signaling is diminished with age and is associated with immune checkpoint blockade efficacy in triple-negative breast cancer","volume":"9","author":"Sceneay","year":"2019"},{"key":"10.1016\/j.prp.2025.156046_bib93","article-title":"Doxorubicin induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates tumor protective immune response in non-small cell lung cancer (NSCLC)","volume":"253","author":"Mukherjee","year":"2024"},{"key":"10.1016\/j.prp.2025.156046_bib94","article-title":"Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma","volume":"4","author":"Chevolet","year":"2015"},{"key":"10.1016\/j.prp.2025.156046_bib95","first-page":"723","article-title":"Indoleamine 2, 3-dioxygenase 1 is highly expressed in glioma stem cells","volume":"524","author":"Ozawa","year":"2020"},{"key":"10.1016\/j.prp.2025.156046_bib96","first-page":"3223","article-title":"Epacadostat plus pembrolizumab in patients with advanced solid tumors: phase I results from a multicenter, open-label phase I\/II trial (ECHO-202\/KEYNOTE-037)","volume":"36","author":"Mitchell","year":"2018"},{"key":"10.1016\/j.prp.2025.156046_bib97","doi-asserted-by":"crossref","first-page":"339","DOI":"10.7150\/ijbs.51241","article-title":"The IFN-\u03b3-IDO1-kynureine pathway-induced autophagy in cervical cancer cell promotes phagocytosis of macrophage","volume":"17","author":"Yang","year":"2021","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.prp.2025.156046_bib98","article-title":"IDO\/Kynurenine; novel insight for treatment of inflammatory diseases","volume":"166","author":"Lashgari","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib99","first-page":"347","article-title":"IDO\/kynurenine pathway in cancer: possible therapeutic approaches","volume":"20","author":"Abd El-Fattah","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib100","first-page":"S1315","article-title":"LBA39 Personalized combination of neoadjuvant domatinostat, nivolumab (NIVO) and ipilimumab (IPI) in stage IIIB-D melanoma patients (pts) stratified according to the interferon-gamma signature (IFN-\u03b3 sign): The DONIMI study","volume":"32","author":"Blank","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib101","first-page":"2930","article-title":"IFN-\u03b3\u2013related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017"},{"key":"10.1016\/j.prp.2025.156046_bib102","first-page":"15","article-title":"Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome","volume":"4","author":"Dinstag","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib103","article-title":"A high interferon gamma signature of CD8+\u2009T cells predicts response to neoadjuvant immunotherapy plus chemotherapy in gastric cancer","volume":"13","author":"Li","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib104","first-page":"7","article-title":"Ratio of the interferon-\u03b3 signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma","volume":"6","author":"Cui","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib105","first-page":"943","article-title":"The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric\/gastroesophageal junction adenocarcinoma","volume":"25","author":"Lu","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib106","article-title":"Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis","volume":"13","author":"Zhang","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib107","article-title":"An IFN-\u03b3-related signature predicts prognosis and immunotherapy response in bladder cancer: Results from real-world cohorts","volume":"13","author":"Deng","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib108","first-page":"2029298","article-title":"MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer","volume":"11","author":"Hagiwara","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib109","first-page":"263","article-title":"IFN-gamma expression in the tumor microenvironment and CD8-positive tumor-infiltrating lymphocytes as prognostic markers in urothelial cancer patients receiving pembrolizumab","volume":"14","author":"Sakatani","year":"2022"},{"key":"10.1016\/j.prp.2025.156046_bib110","article-title":"Serum IL-5 and IFN-\u03b3 Are Novel Predictive Biomarkers for Anti-PD-1 Treatment in NSCLC and GC Patients","volume":"2021","author":"Zhao","year":"2021"},{"key":"10.1016\/j.prp.2025.156046_bib111","first-page":"1540","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016"},{"key":"10.1016\/j.prp.2025.156046_bib112","article-title":"Understanding the theranostic potential of quantum dots in cancer management","volume":"36","author":"Khan","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib113","article-title":"Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer","volume":"643","author":"Khan","year":"2023"},{"key":"10.1016\/j.prp.2025.156046_bib114","series-title":"Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment","author":"Khan","year":"2024"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:31:57Z","timestamp":1778747517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825002390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":114,"alternative-id":["S0344033825002390"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156046","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The paradoxical role of IFN-\u03b3 in cancer: Balancing immune activation and immune evasion","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156046"}}